VRSN
53
-4
CMG
72
5
WAT
55
2
CINF
53
2
SE
61
-4
EMN
60
4
GPC
40
3
ROST
63
12
MPC
44
-3
NDAQ
62
2
XYL
49
4
SNA
68
-2
ISRG
74
-2
SO
53
-4
ES
34
3
ACN
52
3
LMT
34
2
AAP
24
6
WDC
47
4
FLR
58
3
VRSN
53
-4
CMG
72
5
WAT
55
2
CINF
53
2
SE
61
-4
EMN
60
4
GPC
40
3
ROST
63
12
MPC
44
-3
NDAQ
62
2
XYL
49
4
SNA
68
-2
ISRG
74
-2
SO
53
-4
ES
34
3
ACN
52
3
LMT
34
2
AAP
24
6
WDC
47
4
FLR
58
3
Financhill
Back

Sage Therapeutics Stock Price Chart

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27

SAGE
Sage Therapeutics

Last Price:
5.15
Seasonality Move:
13.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Sage Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 5.1 Buy
20-day SMA: 5.94 Sell
50-day SMA: 6.71 Sell
200-day SMA: 11.95 Sell
8-day EMA: 5.19 Sell
20-day EMA: 5.77 Sell
50-day EMA: 6.69 Sell
200-day EMA: 12.01 Sell

Sage Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 35.68 Sell
Chaikin Money Flow: 677330 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.14 - 7.48) Sell
Bollinger Bands (100): (6.13 - 10.09) Sell

Sage Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Sage Therapeutics Stock

Is Sage Therapeutics Stock a Buy?

  • Sage Therapeutics share price is 5.17 while SAGE 8-day simple moving average is 5.10, which is a Buy signal.
  • The stock price of SAGE is 5.17 while Sage Therapeutics 20-day SMA is 5.94, which makes it a Sell.
  • Sage Therapeutics 50-day simple moving average is 6.71 while SAGE share price is 5.17, making it a Sell technically.
  • SAGE stock price is 5.17 and Sage Therapeutics 200-day simple moving average is 11.95, creating a Sell signal.

SAGE Technical Analysis vs Fundamental Analysis

Sell
27
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics a Buy or a Sell?

  • Sage Therapeutics stock is rated a Sell
    The current Sage Therapeutics [SAGE] share price is $5.17. The Score for SAGE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.

Sage Therapeutics Stock Info

Market Cap:
316.27M
Price in USD:
5.17
Share Volume:
870.85K

Sage Therapeutics 52-Week Range

52-Week High:
28.26
52-Week Low:
4.62
Sell
27
Sage Therapeutics (SAGE) is a Sell

Sage Therapeutics Share Price Forecast

Is Sage Therapeutics Stock a Buy?

  • Sage Therapeutics share price is 5.17 while SAGE 8-day exponential moving average is 5.19, which is a Sell signal.
  • The stock price of SAGE is 5.17 while Sage Therapeutics 20-day EMA is 5.77, which makes it a Sell.
  • Sage Therapeutics 50-day exponential moving average is 6.69 while SAGE share price is 5.17, making it a Sell technically.
  • SAGE stock price is 5.17 and Sage Therapeutics 200-day simple moving average is 12.01, creating a Sell signal.

Fundamental Analysis of Sage Therapeutics

Is Sage Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.06 per share, and an increase next year of $2.71 per share.

Technical Analysis of Sage Therapeutics

Should I short Sage Therapeutics stock?

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.